You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CHOLEDYL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Choledyl, and when can generic versions of Choledyl launch?

Choledyl is a drug marketed by Parke Davis and Warner Chilcott Llc and is included in three NDAs.

The generic ingredient in CHOLEDYL is oxtriphylline. There are three drug master file entries for this compound. Additional details are available on the oxtriphylline profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for CHOLEDYL?
  • What are the global sales for CHOLEDYL?
  • What is Average Wholesale Price for CHOLEDYL?
Summary for CHOLEDYL
US Patents:0
Applicants:2
NDAs:3
Raw Ingredient (Bulk) Api Vendors: 37
Patent Applications: 2,913
DailyMed Link:CHOLEDYL at DailyMed
Drug patent expirations by year for CHOLEDYL

US Patents and Regulatory Information for CHOLEDYL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Parke Davis CHOLEDYL oxtriphylline SOLUTION;ORAL 009268-012 Nov 27, 1984 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Parke Davis CHOLEDYL oxtriphylline TABLET, DELAYED RELEASE;ORAL 009268-007 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Parke Davis CHOLEDYL oxtriphylline SYRUP;ORAL 009268-011 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Parke Davis CHOLEDYL oxtriphylline TABLET, DELAYED RELEASE;ORAL 009268-003 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Warner Chilcott Llc CHOLEDYL SA oxtriphylline TABLET, EXTENDED RELEASE;ORAL 086742-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Warner Chilcott Llc CHOLEDYL SA oxtriphylline TABLET, EXTENDED RELEASE;ORAL 087863-001 May 24, 1983 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.